Skip to main content
    C

    Collplant Biotechnologies Ltd (CLGN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.64
    -0.02 (-0.43%)

    Market Cap: $14.27M

    Last updated: Nov 13, 2026 at 4:00 PM ET

    Collplant Biotechnologies Ltd (CLGN) Competitors

    Updated Nov 13, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Collplant Biotechnologies are Pluri (PLUR), Celularity (CELU) and Biocardia (BCDA). By market cap, Collplant Biotechnologies ranks 9th of the 13 companies on this page; Plus Therapeutics (PSTV) is the largest at $26.64M.

    Peer Comparison

    CLGN's revenue growth of -39.7% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Collplant Biotechnologies (CLGN)$14.27MN/A21.0x0.0%N/A-39.7%0.00%
    Pluri Inc. (PLUR)$15.09MN/A8.7x0.0%-650.8%-15.8%0.00%
    Celularity Inc (CELU)$20.45MN/A1.0x-245.7%N/A-5.3%0.00%
    Biocardia Inc (BCDA)$12.58MN/AN/A0.0%N/A-100.0%0.00%
    CytoMed Therapeutics Limited Ordinary Shares (GDTC)$9.90MN/A16.4x0.0%-72.3%-15.9%0.00%
    Context Therapeutics Inc (CNTX)$16.61MN/AN/A0.0%N/A0.0%0.00%
    Chemomab Therapeutics Ltd DRC (CMMB)$12.31MN/AN/A0.0%N/A0.0%0.00%
    Seres Therapeutics Inc (MCRB)$14.27MN/A6.6x0.0%N/A68.9%0.00%
    Pasithea Therapeutics Corp (KTTA)$17.44MN/AN/A0.0%N/A1498.0%0.00%
    Citius Pharmaceuticals Inc (CTXR)$14.69MN/A1.9x0.0%-84.3%0.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Biovie Inc (BIVI)$12.12MN/AN/A0.0%N/A0.0%0.00%
    Akari Therapeutics PLC (AKTX)$15.54MN/AN/A0.0%N/A0.0%0.00%
    Peer median$14.89MN/A4.3x0.0%-367.6%0.0%0.00%
    Market data as of Nov 13, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Collplant Biotechnologies, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Pluri Inc. (PLUR)
    Pluri Inc. is an innovative biotechnology company at the forefront of regenerative medicine and immunotherapy...
    PLUR competitors
    Celularity Inc (CELU)
    Celularity Inc. is a pioneering biotechnology company focused on regenerative medicine through its innovative cellular products derived from the placenta.
    CELU competitors
    Biocardia Inc (BCDA)
    BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease.
    BCDA competitors
    CytoMed Therapeutics Limited Ordinary Shares (GDTC)
    CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human...
    Context Therapeutics Inc (CNTX)
    Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid...
    CNTX competitors
    Chemomab Therapeutics Ltd DRC (CMMB)
    Chemomab Therapeutics Ltd. is dedicated to the research and development of biological drugs for the treatment of inflammatory and fibrotic diseases.
    CMMB competitors
    Seres Therapeutics Inc (MCRB)
    Seres Therapeutics, Inc., a microbiome therapeutic platform company, is involved in the development of bacterial consortia that are designed to functionally...
    MCRB competitors
    Pasithea Therapeutics Corp (KTTA)
    Pasithea Therapeutics Corp. The company is headquartered in Miami Beach, Florida.
    KTTA competitors
    Citius Pharmaceuticals Inc (CTXR)
    Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products.
    CTXR competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Biovie Inc (BIVI)
    BioVie Inc., a clinical-stage biotechnology company, is dedicated to the discovery, development, and commercialization of drug therapies in the United States.
    BIVI competitors
    Akari Therapeutics PLC (AKTX)
    Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for autoinflammatory...
    AKTX competitors

    Frequently Asked Questions About CLGN

    Who are Collplant Biotechnologies' main competitors?

    The companies most similar to Collplant Biotechnologies include Pluri (PLUR), Celularity (CELU), Biocardia (BCDA), CytoMed Therapeutics Limited Ordinary Shares (GDTC) and Context Therapeutics (CNTX), listed from the closest match.

    Who is Collplant Biotechnologies' biggest competitor?

    Plus Therapeutics (PSTV) is the largest of the similar companies at $26.64M; Pluri (PLUR) is the closest match by business profile, size, sector and industry.

    How does CLGN stock compare with its competitors?

    CLGN's P/S is 21.0x against a peer median of 4.3x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Collplant Biotechnologies' competitors pays a higher dividend?

    Collplant Biotechnologies pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Collplant Biotechnologies bigger than its competitors?

    No. Collplant Biotechnologies is 9th by market cap among the 13 companies on this page; the largest is Plus Therapeutics (PSTV) at $26.64M.